MRSN - Mersana Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
10.4 0.2 (1.92%)	---	---	---	0.0 (-0.04%)	0.28 (2.71%)	---	0.0 (-0.04%)

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.19
Diluted EPS:: -0.19
Basic P/E:: -55.7895
Diluted P/E:: -55.7895
RSI(14) 1m:: 45.37
VWAP:: 10.63
RVol:: 1.8064

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	10.65 +0.14 (+1.37%)	Oct 15 15:51
1m	Price decrease 1m	10.51 -0.15 (-1.45%)	Oct 15 15:50
1m	Price decrease 1m	10.51 -0.15 (-1.41%)	Oct 15 15:41
1m	Price decrease 1m	10.31 -0.42 (-3.91%)	Oct 15 15:30
10m	Price decrease 10m	10.31 -0.42 (-3.91%)	Oct 15 15:30